Lexaria Bioscience Corp. research brief
CIK 1348362
Generated Nov. 18, 2026, 8:33 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: KELOWNA British Columbia, Canada. Reported legal jurisdiction: NEVADA. These do not establish investor residence or where funds were deployed.
- Sept. 21, 2026 · D · 0001348362-26-000002 · Source evidence
Reported offering amount: 113492 USD. Reported amount sold: 113492 USD.
- Dec. 19, 2025 · D · 0001348362-25-000018 · Source evidence
Reported offering amount: 3500004 USD. Reported amount sold: 3500004 USD.
- Oct. 1, 2025 · D · 0001348362-25-000017 · Source evidence
Reported offering amount: 4000000 USD. Reported amount sold: 4000000 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Lexaria Bioscience Corp. research brief,” CIK 1348362, retrieved Nov. 18, 2026, 8:33 a.m.. Cite the specific accessions used. No amounts have been summed.